Rare diseases
Investigational molecules
Locations
Back to Italy2 815 clinical trials in Rozzano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Open-Label Study of plozasiran in Adolescents Aged 12 to <18 Years with Familial Chylomicronemia Syndrome
ItalyStudy of galvokimig versus placebo to assess safety and effectiveness in adults with moderate‑to‑severe chronic obstructive pulmonary disease with chronic bronchitis
ItalyPhase 2 Study of Inhaled AGMB-447 and Salbutamol Sulfate in Adults with Idiopathic Pulmonary Fibrosis to Evaluate Lung Function, Safety and Tolerability
ItalySaroglitazar hemimagnesium normalizes alkaline phosphatase in primary biliary cholangitis patients with incomplete response or intolerance to ursodeoxycholic acid
ItalyPhase III Study of Izalontamab Brengitecan with Drug Combination versus Osimertinib Alone in First‑Line EGFR‑Mutated Advanced or Metastatic Non‑Small Cell Lung Cancer
ItalyPhase 3 Study of trastuzumab brengitecan versus platinum‑based chemotherapy in adults with HER2‑positive metastatic urothelial cancer after anti‑PD‑(L)1 therapy
ItalyPhase 2 Study of Apitegromab in Patients with Facioscapulohumeral Muscular Dystrophy
ItalyEffect of Inclisiran, Ezetimibe and Statin Therapy on LDL‑C Levels in Patients with Chronic Coronary Syndrome or Prior Myocardial Infarction
ItalyEfficacy and safety of GIA632 versus placebo in adults with moderate to severe cutaneous lichen planus
ItalyPhase 2 Study of Weekly Ficerafusp Alfa + Pembrolizumab vs Alternative Dosing in First‑Line Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
ItalyPhase 2b Randomized Double‑Blind Study of ALN‑CIDEB in Adults with Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
ItalyLong‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis
ItalyThe busiest research cities in the country
What the registry says about research in the country
Critical investigations focusing on various cancer types including metastatic colorectal cancer, acute myeloid leukemia, and advanced breast cancer. Studies evaluate novel therapeutic combinations and targeted treatments to improve patient outcomes.
Multiple trials exploring innovative treatment approaches for both solid tumors and hematological malignancies.
Research initiatives examining treatments for idiopathic pulmonary fibrosis and chronic respiratory conditions. Studies focus on improving lung function and patient quality of life.
Investigations aim to advance therapeutic options for patients with chronic respiratory conditions.
Comprehensive research into conditions like psoriatic arthritis and systemic sclerosis. Studies evaluate new biological treatments and therapeutic approaches.
Trials focus on developing targeted therapies for various inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
